design-preterm-labor-prevention-plan

Design Preterm Labor Prevention Plan

Apply risk-stratified interventions — progesterone, cervical monitoring, and cerclage — to reduce preterm birth.

Why This Is Best Practice

Adopted by: ACOG, SMFM, RCOG — risk-stratified prevention is the standard of care for women with identified preterm birth risk factors. Impact: Progesterone therapy reduces preterm birth before 34 weeks by 33–45% in high-risk women (Cochrane 2013, 36 RCTs). Short cervix (<25 mm at 16–24 weeks) with vaginal progesterone reduces preterm delivery <33 weeks by 58% (Fonseca et al., NEJM 2007). Why best: Preterm birth is the leading cause of neonatal mortality and morbidity globally. Most cases are not preventable, but identifiable risk factors allow targeted intervention.

Steps

1. Risk stratification at first visit:
   • High risk: prior spontaneous preterm birth <37 weeks (strongest predictor, 20–30% recurrence)
   • Moderate risk: uterine anomalies, prior LEEP/cone biopsy, short cervix in prior pregnancy, smoking, underweight, multiple prior D&Cs
   • Multiple gestation: separate high-risk category; interventions differ
2. Prior preterm birth (singleton):
   • Start 17-alpha-hydroxyprogesterone caproate (17-OHPC, Makena) 250 mg IM weekly from weeks 16–20 through 36 weeks
   • OR vaginal progesterone 200 mg/night (evidence equivalent; patient preference)
3. Universal cervical length screening (weeks 18–24):
   • Transvaginal ultrasound (TVU) cervical length — standard of care in many centers
   • Cervical length <25 mm → offer vaginal progesterone 200 mg/night
4. Short cervix with prior preterm birth:
   • Cervical length <25 mm + prior spontaneous PTB → offer cerclage (surgical cervical suture); SMFM 2020
5. Signs of preterm labor — educate patient to recognize:
   • Regular contractions before 37 weeks (>4/hour)
   • Lower back pain, pelvic pressure, vaginal discharge change
   • Any signs before 37 weeks → go to L&D triage same day
6. For cerclage patients: remove at 36–37 weeks; no intercourse or vaginal exams that could dislodge suture.

Rules

• 17-OHPC evidence was contested by FDA in 2023 — discuss current evidence with MFM before prescribing; vaginal progesterone remains well-supported.
• Do not use tocolytics (nifedipine, indomethacin) as long-term prevention — they are for acute preterm labor only.
• Cervical length shortening is often asymptomatic — it is only detectable by TVU, not clinical exam.

Examples

Prior 33-week delivery (singleton): Cervical length check at 16, 18, 20, 22 weeks; start vaginal progesterone at 16 weeks; cerclage if CL <25 mm at 18 weeks. Asymptomatic short cervix (22 mm at 20 weeks), no prior PTB: Start vaginal progesterone 200 mg nightly; re-check CL in 2–3 weeks.

Common Mistakes

• Waiting for symptoms to start intervention — by the time contractions begin, cervix may already be dilated.
• Using multiple gestation protocols for singleton — progesterone does not prevent preterm birth in multiples (increases risk in some studies).
• Not referring to MFM for cerclage decision — cerclage has specific indications; placing without criteria increases preterm labor risk.

Health Disclaimer: Preterm birth prevention requires specialist involvement. Refer to a maternal-fetal medicine (MFM) specialist for cervical length <25 mm, prior preterm birth, or any suspected preterm labor. Go to L&D triage for any contractions before 37 weeks.